0000904454-13-001105.txt : 20131011 0000904454-13-001105.hdr.sgml : 20131011 20131011172015 ACCESSION NUMBER: 0000904454-13-001105 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130924 FILED AS OF DATE: 20131011 DATE AS OF CHANGE: 20131011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 CITY: SAN DIEGO STATE: CA ZIP: 92122 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 CITY: SAN DIEGO STATE: CA ZIP: 92122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TIDMARSH GEORGE F CENTRAL INDEX KEY: 0001287235 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24274 FILM NUMBER: 131148627 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-09-24 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001287235 TIDMARSH GEORGE F 4370 LA JOLLA VILLAGE DRIVE SUITE 400 SAN DIEGO CA 92122 1 1 0 0 Pres, CEO, Sec'y Common Stock 2013-09-24 4 A 0 66352429 A 68332871 D Stock Option (Right to Buy) .06 2012-04-10 4 D 0 506300087 D 2022-04-10 Common Stock 506300087 0 D On September 24, 2013, the Issuer cancelled, pursuant to the Restricted Stock Purchase Agreement entered into and between the Issuer and the Reporting Person, an option granted to the Reporting Person on April 10, 2012. In exchange for the forfeiture of the option and the RSUs, the Reporting Person received 66,352,429 shares of restricted Common Stock. The cancelled option provided for vesting with respect to one-quarter of the underlying shares on January 19, 2013 and, with respect to the remaining shares, monthly thereafter over the next three years. /s/ George F. Tidmarsh 2013-10-09